Hipromine (WAR:HPM) Other Stockholders Equity: zł80.25 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:HPM Hipromine SA WAR:HPM
53 GF Score
Price zł80.00
GF Value zł856.24
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Hipromine Other Stockholders Equity?

Hipromine WAR:HPM 53 Other Stockholders Equity is zł80.25 Mil as of Mar. 2026. GuruFocus rates WAR:HPM with a GF Score™ of 53/100 and a GF Value™ of zł856.24 (Possible Value Trap). The stock has 7 warning signs investors should review.

Hipromine's Other Stockholders Equity for the quarter that ended in Mar. 2026 was zł80.25 Mil.

Hipromine's quarterly Other Stockholders Equity declined from Sep. 2025 (zł183.34 Mil) to Dec. 2025 (zł80.25 Mil) but then increased from Dec. 2025 (zł80.25 Mil) to Mar. 2026 (zł80.25 Mil).

Hipromine's annual Other Stockholders Equity increased from Dec. 2023 (zł0.00 Mil) to Dec. 2024 (zł149.29 Mil) but then declined from Dec. 2024 (zł149.29 Mil) to Dec. 2025 (zł80.25 Mil).

Hipromine Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Hipromine's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hipromine Other Stockholders Equity Chart

Hipromine Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial 51.22 0.00 0.00 149.29 80.25

Hipromine Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 149.11 0.00 183.34 80.25 80.25
WAR:HPM
53GF Score
Hipromine SA WAR:HPM
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hipromine Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of zł80.25 Mil mean?
Hipromine (WAR:HPM) has a Other Stockholders Equity of zł80.25 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Hipromine and its competitors.
Is Hipromine's Other Stockholders Equity too high?
Hipromine's current Other Stockholders Equity is zł80.25 Mil. Overall, Hipromine has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hipromine's Other Stockholders Equity compare to KHC and GIS?
Hipromine's Other Stockholders Equity of zł80.25 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Consumer Packaged Goods company?
A good Other Stockholders Equity depends on the Consumer Packaged Goods industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Hipromine and its competitors. Hipromine's current Other Stockholders Equity is zł80.25 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hipromine stock overvalued right now?
Based on GuruFocus' analysis, Hipromine (WAR:HPM) is currently considered Possible Value Trap. The stock's GF Value™ is zł856.24, compared to a current price of zł80.00 — trading 90.7% below its estimated fair value. The current Other Stockholders Equity is zł80.25 Mil. Hipromine's overall GF Score™ is 53/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Hipromine (WAR:HPM), the current Other Stockholders Equity is zł80.25 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hipromine (WAR:HPM) Overvalued in 2026?

Based on GuruFocus' analysis, Hipromine stock appears to be undervalued. The current stock price of zł80.00 is trading 90.7% below its estimated GF Value™ of zł856.24. GuruFocus considers Hipromine to be Possible Value Trap.

Key valuation signals for WAR:HPM:

  • Other Stockholders Equity: zł80.25 Mil
  • GF Value™: zł856.24 vs. price of zł80.00 (90.7% below fair value)
  • GF Score™: 53/100 with 7 warning signs

No single metric tells the full story. See the WAR:HPM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hipromine Business Description

Address ul. Poznańska, 12th Floor, Robakowo, POL, 62-023
Hipromine SA is a European scale supplier of an alternative protein produced through innovative, proprietary technology of industrial insect breeding. The company's offer is directed mainly to the market of pet food and fodder for fish farming, as well as livestock and horticulture.
53GF Score

Get the complete analysis for WAR:HPM

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł80.00
Price
zł856.24
GF Value